Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance Conference
BANNOCKBURN, Ill. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate treatment site infusion therapy services, will present at the Bank of America Merrill Lynch 2019 Leveraged Finance Conference on December 3,
Toggle Summary Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment
National leader in treating bleeding disorders offers personalized, high-quality patient care BANNOCKBURN, Ill. , Nov. 19, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. , the nation’s largest independent provider of home and alternate treatment site infusion therapy services, has been chosen by
Toggle Summary Option Care Health Announces Third Quarter Results
BANNOCKBURN, Ill. , Nov. 06, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (Nasdaq: BIOS), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the third quarter ended September 30, 2019 .
Toggle Summary Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , Oct. 16, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the Company will release results for its third quarter ended September 30, 2019 on
Toggle Summary Option Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
BANNOCKBURN, Ill. --(BUSINESS WIRE)--Aug. 29, 2019-- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that John Rademacher , Chief Executive Officer, will participate in a fireside chat on
Toggle Summary Option Care and BioScrip Complete Merger to Form Option Care Health
Largest Independent Home and Alternate Site Infusion Provider Establishes the Standard of Care Across the United States Through Its Clinical Leadership and Technology-Enabled Patient-Centered Model BANNOCKBURN, Ill. & DENVER --(BUSINESS WIRE)--Aug. 7, 2019-- Option Care Enterprises, Inc.
Toggle Summary BioScrip Announces Shareholder Approval of Merger with Option Care
DENVER , Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the “Company”), the largest independent national provider of infusion and home care management solutions, today announced that its stockholders approved the proposals that are conditions to the proposed merger
Toggle Summary BioScrip Reports Second Quarter 2019 Financial Results
DENVER , July 30, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2019 financial results.
Toggle Summary Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care
DENVER , July 22, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co.
Toggle Summary Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger
DENVER , June 13, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that key members of BioScrip’s leadership team will continue in executive roles with the combined company